Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis

Irene Cacciola, Roberto Filomia, Angela Alibrandi, Maria Stella Franzè, Gaia Caccamo, Sergio Maimone, Carlo Saitta, Francesca Saffioti, Giovanni Squadrito, Giovanni Raimondo
  • Liver International, January 2018, Wiley
  • DOI: 10.1111/liv.13649

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/liv.13649

The following have contributed to this page: Professor Giovanni Squadrito